Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PV-001 by Posvax for Human Papillomavirus Infections: Likelihood of Approval
PV-001 is under clinical development by Posvax and currently in Phase I for Human Papillomavirus Infections. According to GlobalData, Phase...